Adult stem cell

BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award

Retrieved on: 
Monday, September 16, 2019
Biology, Branches of biology, Life sciences, Biotechnology, Stem cells, Cell biology, Communication, Forward-looking statement, Adult stem cell

Dr. Olan has been a member of the Companys Scientific Advisory Board since 2014 and its Disc Advisory Committee since its creation in early 2019.

Key Points: 
  • Dr. Olan has been a member of the Companys Scientific Advisory Board since 2014 and its Disc Advisory Committee since its creation in early 2019.
  • BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.
  • The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

Study shows Mesenchymal Stromal Cells importance of tissue origin in predicting function

Retrieved on: 
Tuesday, September 10, 2019
Branches of biology, Biology, Stem cells, Life sciences, Cancer stem cell, Stem-cell niche, Embryonic stem cell, Adipose tissue, Mesenchymal stem cell, Adult stem cell

DURHAM, N.C., Sept. 10, 2019 /PRNewswire-PRWeb/ --A new study released today in STEM CELLS demonstrates that mesenchymal stromal cells (MSCs) expanded from adipose tissue (ASC) outperform those expanded from bone marrow (BM-MSCs).

Key Points: 
  • DURHAM, N.C., Sept. 10, 2019 /PRNewswire-PRWeb/ --A new study released today in STEM CELLS demonstrates that mesenchymal stromal cells (MSCs) expanded from adipose tissue (ASC) outperform those expanded from bone marrow (BM-MSCs).
  • "However, the influence of their tissue of origin on their functional properties, including their immunosuppressive activity, remains unsolved.
  • We demonstrated for the first time on a large series of ASCs and BM-MSCs, obtained from the same donors, the strong impact of tissue origin on these cells' properties.
  • The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research.

BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Comprehensive Corporate Update

Retrieved on: 
Monday, August 5, 2019
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Developmental biology, Induced stem cells, Cell biology, Mesenchymal stem cell, Adult stem cell, Cellular differentiation, Draft:BrainStorm Cell Therapeutics

MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo.

Key Points: 
  • MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo.
  • MSCs are converted into MSC-NTF cells by growing them under patented conditions that induce the cells to secrete high levels of neurotrophic factors.
  • BrainStorm is currently conducting a Phase 3 pivotal trial of autologous MSC-NTF cells for the treatment of amyotrophic lateral sclerosis (ALS).
  • About BrainStorm Cell Therapeutics Inc.
    BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.

Global Stem Cell Assay Industry

Retrieved on: 
Tuesday, July 30, 2019
Branches of biology, Biology, Life sciences, Biotechnology, Stem cells, Assay, Biochemistry, Titration, Adult stem cell

Differentiation (Type) Market Share Shift by Company: 2019 & 2025

Key Points: 
  • Differentiation (Type) Market Share Shift by Company: 2019 & 2025
    Proliferation (Type) Market Share Breakdown of Key Players:
    Adult Stem Cells (Cell Type) Market Share Shift by Company:
    Instruments (Product) Market Share Breakdown of Key Players:
    Services (Product) Market Share Shift by Company: 2019 & 2025
    in US$ Million by Region/Country: 2018-2025
    in US$ Million by Region/Country: 2018 to 2025
    Table 7: Isolation & Purification (Type) Potential Growth MARKETs Worldwide in US$ Million: 2018 to 2025
    of Worldwide Sales by Region/Country: 2019 VS 2025
    Worldwide in US$ Million by Region/Country: 2018 to 2025
    Forecasts by Region/Country in US$ Million: 2018 to 2025
    Opportunity Assessment in US$ Million by Region/Country:
    Breakdown of Global Sales by Region/Country: 2019 VS 2025
    Table 21: Drug Discovery & Development (Application) Global MARKET Estimates & Forecasts in US$ Million by Region/Country:
    of Worldwide Sales by Region/Country: 2019 VS 2025
    Demand Potential Worldwide in US$ Million by Region/Country:
    Share Breakdown Review by Region/Country: 2019 VS 2025
    Forecasts in US$ Million by Region/Country: 2018-2025
    by Region/Country in US$ Million: 2018 to 2025
    US Stem Cell Assay Market Share (in %) by Company: 2019 & 2025
    Differentiation (Type) Market in the US: Percentage Breakdown
    Key Players in the US: 2019 & 2025
    Instruments (Product) Market in the US: Percentage Breakdown of
    Key Players in the US: 2019 & 2025
    Projections in US$ Million by Type: 2018 to 2025
    in US$ Million by Application: 2018 to 2025
    Projections in US$ Million by Cell Type: 2018 to 2025
    in US$ Million by End-Use: 2018 to 2025
    Projections in US$ Million by Product: 2018 to 2025
    Forecasts in US$ Million by Type: 2018 to 2025
    Table 48: Stem Cell Assay Market in Canada: Percentage Share
    Analysis in US$ Million by Application: 2018 to 2025
    Forecasts in US$ Million by Cell Type: 2018 to 2025
    Table 52: Stem Cell Assay Market in Canada: Percentage Share
    Analysis in US$ Million by End-Use: 2018 to 2025
    Forecasts in US$ Million by Product: 2018 to 2025
    Table 56: Stem Cell Assay Market in Canada: Percentage Share
    Table 57: Japanese Market for Stem Cell Assay: Annual Sales
    Assay in US$ Million by Application: 2018 to 2025
    Table 61: Japanese Market for Stem Cell Assay: Annual Sales
    Assay in US$ Million by End-Use: 2018 to 2025
    Table 65: Japanese Market for Stem Cell Assay: Annual Sales
    Table 68: Chinese Stem Cell Assay Market by Type: Percentage
    Table 72: Chinese Stem Cell Assay Market by Cell Type:
    Table 76: Chinese Stem Cell Assay Market by Product: Percentage
    European Stem Cell Assay Market: Competitor Market Share
    Differentiation (Type) Market in Europe: Competitor Revenue
    Apoptosis (Type) Market Share (in %) by Company in Europe: 2019
    Instruments (Product) Market in Europe: Competitor Revenue
    Forecasts in US$ Million by Type: 2018-2025
    Opportunity in US$ Million by Application: 2018-2025
    Forecasts in US$ Million by Cell Type: 2018-2025
    Opportunity in US$ Million by End-Use: 2018-2025
    Forecasts in US$ Million by Product: 2018-2025
    Table 89: Stem Cell Assay Market in France by Type: Estimates
    Table 90: French Stem Cell Assay Market Share Analysis by Type:
    France in US$ Million by Application: 2018-2025
    Table 92: French Stem Cell Assay Market Share Analysis: A
    Table 93: Stem Cell Assay Market in France by Cell Type:
    France in US$ Million by End-Use: 2018-2025
    Table 96: French Stem Cell Assay Market Share Analysis: A
    Table 97: Stem Cell Assay Market in France by Product:
    Table 99: Stem Cell Assay Market in Germany: Recent Past,
    Table 101: Stem Cell Assay Market in Germany: Annual Sales
    Table 103: Stem Cell Assay Market in Germany: Recent Past,
    Table 105: Stem Cell Assay Market in Germany: Annual Sales
    Table 107: Stem Cell Assay Market in Germany: Recent Past,
    Table 110: Italian Stem Cell Assay Market by Type: Percentage
    Table 114: Italian Stem Cell Assay Market by Cell Type:
    Table 118: Italian Stem Cell Assay Market by Product:
    Table 119: United Kingdom Market for Stem Cell Assay: Annual
    Stem Cell Assay in US$ Million by Application: 2018 to 2025
    Table 123: United Kingdom Market for Stem Cell Assay: Annual
    Stem Cell Assay in US$ Million by End-Use: 2018 to 2025
    Table 127: United Kingdom Market for Stem Cell Assay: Annual
    Forecasts in US$ Million by Type: 2018-2025
    Opportunity in US$ Million by Application: 2018-2025
    Forecasts in US$ Million by Cell Type: 2018-2025
    Opportunity in US$ Million by End-Use: 2018-2025
    Forecasts in US$ Million by Product: 2018-2025
    Table 139: Stem Cell Assay Market in Asia-Pacific by Type:
    Asia-Pacific in US$ Million by Application: 2018-2025
    Table 142: Asia-Pacific Stem Cell Assay Market Share Analysis:
    Table 143: Stem Cell Assay Market in Asia-Pacific by Cell Type:
    Asia-Pacific in US$ Million by End-Use: 2018-2025
    Table 146: Asia-Pacific Stem Cell Assay Market Share Analysis:
    Table 147: Stem Cell Assay Market in Asia-Pacific by Product:
    Forecasts in US$ Million by Type: 2018 to 2025
    Table 150: Stem Cell Assay Market in Rest of World: Percentage
    Demand Analysis in US$ Million by Application: 2018 to 2025
    Forecasts in US$ Million by Cell Type: 2018 to 2025
    Table 154: Stem Cell Assay Market in Rest of World: Percentage
    Demand Analysis in US$ Million by End-Use: 2018 to 2025
    Forecasts in US$ Million by Product: 2018 to 2025
    Table 158: Stem Cell Assay Market in Rest of World: Percentage

Century Therapeutics Launches With USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform

Retrieved on: 
Monday, July 1, 2019
Stem cells, Biotechnology, Pharmaceutical, Oncology, Health, Other Health, Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Developmental biology, Cell biology, Induced pluripotent stem cell, Adult stem cell, Cellular differentiation, Induced stem cells, Stem-cell line, Century Therapeutics, Bayer and Leaps by Bayer, Versant Ventures, Fujifilm, Fujifilm Cellular Dynamics, Inc. (FCDI)

Centurys foundational technology is built on induced pluripotent stem cells (iPSCs) that have unlimited self-renewing capacity.

Key Points: 
  • Centurys foundational technology is built on induced pluripotent stem cells (iPSCs) that have unlimited self-renewing capacity.
  • This platform differentiates Century from competitors that are developing cell therapies made from non-renewable donor-derived cells.
  • It represents a unique opportunity in the development of next generation cell therapies that promise to address previously incurable cancers.
  • Century Therapeutics is harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer.

Optimum Wellness Solutions Now Provides Stem Cell Treatments

Retrieved on: 
Tuesday, June 25, 2019
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Cell biology, Induced stem cells, Stem-cell therapy, Cell therapy, Adult stem cell

RICHARDSON, Texas, June 25, 2019 /PRNewswire-PRWeb/ --Optimum Wellness Solutions in Richardson, TX, is pleased to announce that they now provide stem cell treatments!

Key Points: 
  • RICHARDSON, Texas, June 25, 2019 /PRNewswire-PRWeb/ --Optimum Wellness Solutions in Richardson, TX, is pleased to announce that they now provide stem cell treatments!
  • Optimum Wellness Solutions focuses on unique healing experiences that merge traditional philosophies with the latest technologies, and stem cell treatments are the natural next step.
  • All treatments use only umbilical cord stem cells voluntarily donated by mothers at the time of a healthy live birth.
  • In stem cell therapy, a targeted injection of stem cells actually restarts the process of healing.

Incubation with Extracellular Vesicles Boosts Cells' Grafting Ability

Retrieved on: 
Tuesday, June 11, 2019
Branches of biology, Biology, Cell biology, Stem cells, Mesenchymal stem cell, CD34, Stem cell, Extracellular vesicle, Adult stem cell, Stem cell transplantation for articular cartilage repair

DURHAM, N.C., June 11, 2019 /PRNewswire-PRWeb/ -- A study released today in STEM CELLS demonstrates how extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying their gene expression and increasing their viability and cloning ability.

Key Points: 
  • DURHAM, N.C., June 11, 2019 /PRNewswire-PRWeb/ -- A study released today in STEM CELLS demonstrates how extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying their gene expression and increasing their viability and cloning ability.
  • In a test on mice, MSC-EVs also increased the cells' ability to lodge into bone marrow.
  • "In the current work, we wanted to evaluate the changes induced in CD34+ cells after the incorporation of MSC-derived EV.
  • Moreover, we have assessed if this incorporation has functional implications, evaluating their clonogenic ability in vitro and the in vivo engraftment in a mouse model."

Cell Expansion Market - Global Forecast to 2024

Retrieved on: 
Friday, May 3, 2019
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Developmental biology, Induced stem cells, Cell biology, Adult stem cell, Regeneration, Induced pluripotent stem cell

7.2.1.1.1 Adult Stem Cells Segment Accounts for the Largest Share of the Human Stem Cells Market, Primarily Due to Increased Government Initiatives in Cell-Based Research

Key Points: 

7.2.1.1.1 Adult Stem Cells Segment Accounts for the Largest Share of the Human Stem Cells Market, Primarily Due to Increased Government Initiatives in Cell-Based Research
7.2.1.2.1 IPSCS are Sued in Cell Replacement Therapies, Drug Screening, and Tissue Regeneration

Global $15.63Bn Stem Cell Market by Product, Application, Technology, Therapy, and Region - Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 18, 2019
Stem cells, Health, Research, Science, Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Induced stem cells, Cloning, Developmental biology, Adult stem cell

The global stem cell market size is expected to reach USD 15.63 billion by 2025, at a CAGR of 8.8% during the forecast period.

Key Points: 
  • The global stem cell market size is expected to reach USD 15.63 billion by 2025, at a CAGR of 8.8% during the forecast period.
  • Amplifying research studies targeted at widening the utility scope of stem cell products is anticipated to drive the growth.
  • These research projects are set to offer new opportunities for implementation of several clinical applications of stem cells.
  • Adult stem cells displayed highest contribution in the market and is expected to maintain its dominance over the forecast period.

Worldwide Stem Cell Market Growth, Trends and Forecasts Analysis (2019-2024) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 27, 2019
Stem cells, Health, Branches of biology, Biology, Life sciences, Biotechnology, Stem cells, Induced stem cells, Cloning, Developmental biology, Adult stem cell

The Stem Cell Market is expected to register a CAGR of nearly 10.04% during the forecast period, 2019-2024.

Key Points: 
  • The Stem Cell Market is expected to register a CAGR of nearly 10.04% during the forecast period, 2019-2024.
  • The stem cell market is experiencing growth, owing to the increasing number of clinical trials around the world.
  • North America dominated the overall stem cell market with the United States contributing to the largest share in the market.
  • Such numerous stem cell studies across the United States have helped in the growth of the stem cell market.